Definium Therapeutics
Neurology & CNS Therapeutics · Psychiatric Care

Definium Therapeutics news and milestones

Definium Therapeutics: 12 headlines on record, 6 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 18, 2026 · Back to the company report
12Headlines
6In 90 days
1Milestones

Headlines

Sep 302026
News · YahooFinance
Robert Barrow, Director, Chief Executive Officer, on September 25, 2026, sold 31,550 shares in Defin
Sep 182026
Press release · The Globe and Mail
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
Sep 182026
Press release · The Globe and Mail
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
Sep 152026
News · YahooFinance
Definium Therapeutics has ridden a powerful three year run, and that surge now puts a spotlight on a simple question for investors who care about balance sheets. Is the current s…
Sep 152026
News · YahooFinance
Definium Therapeutics (DFTX) just reported that its second Phase 3 Panorama trial of DT120 ODT in generalized anxiety disorder met primary and key secondary endpoints, with clini…
Aug 122026
Blog
Our team met in the nation's capital with lawmakers, clinical researchers and advocates to discuss the ongoing research in psychedelic medicines and what the future holds for the…
Aug 122026
Blog
This is the third edition of Forward Focus, a regular feature exploring the future of mental health with precision and purpose. Psychiatry is at an inflection point. Recently, De…
Aug 122026
Blog
The post Landmark Order Advances Breakthrough Mental Health Treatments appeared first on Definium Therapeutics.
Sources: the outlets named on each headline, each story once

Milestones

Oct 2026
Went public NASDAQ: DFTX
Each milestone is dated by its source: registers, filings, the press

How to cite

Definium Therapeutics, News. Alion, Nov 18, 2026. https://alion.io/company/definiumtx/news

.json · .md · CC BY-SA 4.0